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Article
Comparison of two alternative wound
closure methods for tumor arthroplasty of
the hip: A frequencymatched cohort study
Werner H Hettwer1, Peter F Horstmann1, Chunsen Wu2,3
and Michael M Petersen1
Abstract
Objective: To examine the effect of an alternative wound closure method after tumor arthroplasty of the hip compared
to routine wound closure with skin staples. Method: Single center, frequency matched cohort study. We reviewed all
patients who underwent tumor resection and endoprosthetic reconstruction of the proximal femur for pathologic
fracture due to metastatic bone disease or malignant hematologic bone disease at our center between 2010 and 2014. All
patients treated with occlusive wound closure (OWC), a combination of intradermal suture, Steri-Strips™, and an
occlusive skin adhesive, during this period (n ¼ 35), were compared to an equally sized frequency matched group of
patients having undergone routine wound closure with conventional skin staples. Results: Patients with OWC were
significantly faster to achieve dry wound status and consequently had significantly shorter administration of antibiotics and
hospital stay. Compared to the patients with conventional wound closure with staples, their wounds were already dry
after a mean 3.4 days (vs. 6.7 days [95%CI: 3–3.8 vs. 5.5–7.9], p < 0.0001), they received antibiotics for a mean 4.2 days (vs.
6.8 days [95%CI: 3.7–4.8 vs. 5.5–8.0], p < 0.0003) and their mean hospital stay was 6.3 days (vs. 8.0 days [95%CI: 5.5–7 vs.
6.8–9.3], p < 0.015). Prolonged wound discharge (PWD) for 7 days or more was observed in 34% of patients (n ¼ 12) in
the conventional group, whereas this complication was completely absent (n ¼ 0) in the investigational group. For every
three patients treated with OWC, one complication of PWD over 7 days is avoided (number needed to treat ¼ 3).
Conclusion: Compared to conventional staples, OWC appears to significantly reduce wound complications, use of
antibiotics, and hospital stay in patients undergoing tumor arthroplasty procedures of the hip. As such, it may also
contribute to a reduction of the substantially increased risk for prosthetic joint infection in this patient population.
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Introduction
Prosthetic joint infection (PJI) remains one of the major
complications of endoprosthetic reconstruction surgery and
is particularly common (10–11%)1,2 when performed in
conjunction with resection of malignant bone tumors. It
is a serious complication per se and typically requires fur-
ther single-stage or multistage revision surgery, prolonged
hospitalization, antibiotic treatment, and rehabilitation.
Moreover, PJI predisposes patients with bone tumors
to particular further risks and complications, such as
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amputation,1–3 and may interfere with adjuvant radio- and/
or chemotherapy, which can compromise local tumor con-
trol and overall survival. The substantial cost associated
with the treatment required for these complications is also
well-known.4 Prolonged wound discharge (PWD) is a well-
documented predisposing risk factor for surgical site infec-
tion5–9 and may result in prolonged hospital stay and delay
of adjuvant therapy. While reported to be a relatively
uncommon complication of conventional hip arthroplasty
(4%),10 PWD appears to have a considerably higher inci-
dence in orthopedic tumor patients (48%).11 Our routine
practice has therefore been to pre-emptively treat all our
patients undergoing tumor resection and endoprosthetic
reconstruction with prolonged prophylactic intravenous
antibiotics until the surgical wound is completely dry.12
In an effort to address the substantial rate of PWD in this
patient population, identified in a previous study,11 one
surgeon (WH) changed his wound closure method in
2013, while three other senior surgeons initially continued
their usual technique with conventional skin staples. This
study was conducted to investigate the clinical effect of an
alternative wound closure method on the incidence of PWD
and possible secondary effects on the duration of adminis-
tration of postoperative intravenous antibiotic prophylaxis
and the length of the hospital stay after endoprosthetic
reconstruction of the proximal femur performed in patients
with a secondary or hematologic malignancy of bone.
Materials and methods
Study design and patient population
We retrospectively reviewed the medical records of all
patients with metastatic bone disease and malignant hema-
tologic bone disease who underwent endoprosthetic recon-
struction of the proximal femur in our specialized
orthopedic oncology unit between 2010 and 2014. All vital
data (age, gender, nature and location of pathology, tumor
type and growth rate, details of the surgical procedure,
implants used, method of wound closure, time to dry sur-
gical wound, duration of antibiotic treatment, and length of
hospital stay) were collected from the patient files. We
identified 42 patients having received occlusive wound
closure (OWC) with a combination of intradermal suture,
Steri-Strips™, and an occlusive skin adhesive. Six patients
were excluded on the basis of either primary pathology
(bone sarcoma, n ¼ 3) or extent of the surgical procedure
(pelvic reconstruction, n ¼ 3), as we have previously iden-
tified these variables to be independent risk factors for
PWD.11 One patient was not included due to immediate
postoperative death following cardiac arrest. This left us
with a group of n ¼ 35 consecutive patients treated with
OWC after tumor resection for metastatic or malignant
hematologic bone disease and endoprostetic reconstruction
of the proximal femur in our department between Decem-
ber 2012 and October 2014 (investigational group). We
then identified a matching group of (n ¼ 35) patients with
corresponding surgical intervention except for conven-
tional wound closure with staples (conventional group)
from the primary patient population described above, such
that the distribution of the relevant demographic character-
istics (age, gender, tumor growth rate, and overall survival)
and matching criteria (age, gender, extent of resection,
hemiarthroplasty vs. total endoprosthesis, and presence or
absence of a pathological fracture) were similar, respec-
tively identical to the distribution in the patients in the
investigational group (Table 1). The indication for surgical
treatment was de facto pathological fracture in 21 patients
and impending pathological fracture in 14 patients in
either group. Conventional femoral neck resection was
performed in 19 patients as opposed to proximal femoral
resection in 16 patients per group and 25 patients per
group received a total joint arthroplasty with both femoral
and acetabular components, whereas 10 patients in each
group received a cemented hemiarthroplasty. As the
extent of resection (proximal femur vs. conventional neck
cut) had proven not to be a significant confoundig factor
for PWD (p ¼ 0.46) in a previous study,11 we did not
divide our relatively small study population into further
subgroups. None of the patients received active che-
motherapy during their hospital stay or at least 2 weeks
prior to surgery. All patients with renal cell cancer metas-
tases underwent pre-operative embolization to reduce
intraoperative blood loss. Complete data without missing
observations were available for postoperative survival,
wound status, duration of antibiotic administration, and
duration of hospital stay, in all 70 cases.
Ethical considerations
As a purely retrospective review of patient records without
involvement of any direct patient contact, this study was
not considered notifiable to the ethical board. Danish Data
Protection Agency approval was obtained prior to com-
mencement of data collection (J.no: 2013-412591)
Surgical procedure
A routine posterior approach to the hip was employed in all
patients. Confinement of the tumor to the femoral head or
neck allowed a conventional neck resection, preservation
of the abductor mechanism and endoprosthetic reconstruc-
tion with a standard (Biomet Bimetric (n ¼ 5)) or a long
(200 mm or longer) femoral stem (link: SP2 (n¼ 18) or MP
(n ¼ 2)) (implantcast: long stem (n ¼ 10), RS (n ¼ 1) or
Mutars (n ¼ 1)) or Zimmer CPT (n ¼ 1) in 19 patients per
group (n ¼ 38)). The remaining 16 patients in each group
(n¼ 32) required an extended posterior approach to accom-
modate the necessary proximal femoral resection (mean
resection length 141 mm (range 120–220 mm) in group 1
versus mean resection length 140 mm (range 110–216) in
group 2) and subsequent endoprosthetic reconstruction
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with a dedicated segmental tumor prosthesis (Zimmer Seg-
mental (n¼ 30)) or a modular revision stem (Link MP (n¼
2)). All femoral components were cemented, whereas treat-
ment of the acetabular side was treated according to local
condition of the joint surface and surgeon preference. The
majority of patients received a cemented acetabular com-
ponent (Lubinus Excentric (n ¼ 47)), 10 patients per group
had a hemiarthroplasty (Zimmer Multipolar (n¼ 20)) and 3
patients in the control group had an uncemented cup (Zim-
mer Trilogy (n ¼ 2), Biomet Ranawat (n ¼ 1)).
Wound closure and postoperative routine
After reattachment of residual musculature to the prosthesis
using nonabsorbable suture (Nr.5 Fibrewire, Arthrex
GmbH, Munich, Germany), a deep submuscular drain was
inserted if considered necessary. Fascia and deep subcuta-
neous layers were then closed using nr1. Vicryl (Ethicon,
Somerville, New Jersey, USA) interrupted sutures with
particular attention to leaving minimal residual dead space
and to obtain level skin edge approximation. Superficial
closure followed with a neat, skin edge adapting layer of
interrupted 2-0 Vicryl (Ethicon) subdermal sutures placed
in inverted fashion. The skin was then either closed with a
meticulous intradermal running horizontal matress
suture (3-0 Vicryl RapidTM; Ethicon), tightly adjacent
Steri-Strips™ (3 M Health Care, St Paul, Minnesota, USA)
for fine adaptation and optimal skin approximation before
final application of a flexible occlusive skin adhesive
(2-octyl cyanoacrylate, Liquiband Flex; AMS Ltd, Ply-
mouth, UK; group I, interventional group), or conventional
staples (Appose ULC Slim Body Skin Stapler, Covidien,
Massachusetts, USA; group II, control group) and covered
with a sterile wound dressing (Mepilex Border Post-Op;
Mo¨lnicke Health Care, Go¨teborg, Sweden) and soft com-
pressive bandage. Postoperatively all patients were mobi-
lized, weight bearing as tolerated, from postoperative day
1. The sterile compressive dressing applied at conclusion
of the procedure was left unchanged until day 2 or 3 to
coincide with removal of any surgical drains still present.
Prophylactic intravenous antibiotics (cefuroxime, 1.5 g 
3) were started 15–30 min prior to incision and not dis-
continued before a senior member of the surgical team
considered the wound dry. Thromboprophylaxis with tin-
zaparin 3500–4500 IE  1 sc. was maintained until the
patients were well mobilized, at least until discharge from
hospital.
Statistical analysis
Due to lack of generally accepted criteria of PWD, we
calculated risk ratio (RR), risk differences, and number
needed to treat for PWD of patients treated with OWC
compared to that of patients undergoing routine wound
closure with conventional skin staples according to a
range of duration of drainage, respectively. Afterward, the
data were modeled as time to events (outcomes) of inter-
est, including completely dry wound, termination of anti-
biotic treatment, and hospital discharge, respectively.
Kaplan–Meier survival analysis was applied to estimate
the overall survival function for each of the outcomes of
interest, which were then also analyzed using Cox propor-
tional hazard models. The patients were followed up from
the day of operation until the occurrence of the outcomes
of interest, with follow-up time in days used as the under-
lying time scale. We verified that the assumptions for
proportional hazards were not seriously violated using
log–log plots. We performed crude analyses to estimate
mean survival days with 95% confidence interval (95%
CI) and hazard ratios (HRs) with 95% CI and then
adjusted the HRs for potential confounders including gen-
der, age, and tumor growth rate, which we categorized
according to Katagiri13 into slow, intermediate, or fast
growth (Table 1). p-Values less than 0.05 are considered
significant. All statistical analyses were performed using
STATA version 14 (Stata Corp., College Station, Texas,
USA).
Table 1. Demographics, pathology, matching criteria and overall
survival of all patients in both groups.
Investigational
group (occlusive
wound closure)
Conventional
group (skin
staples)
Number of patients (n) 35 35
Female/male 20/15 20/15
Mean age at surgery (years)
(range)
68 (47–87) 63 (32–86)
Primary tumor
Slow growth
Breast 12 15
Prostate 8 4
Myeloma 3 2
Intermediate growth
Kidney 3 4
Bladder 2 —
Lymphoma — 1
Uterus 1 —
Fast growth
Lung 4 5
Esophagus — 1
Submandibular gland 1 —
Colon — 1
Oncocytic carcinoma — 1
Unknown 1 1
Clinical criteria
Pathological fracture (y/n) 21/14 21/14
Proximal femur resection (y/n) 16/19 16/19
Total/hemiarthroplasty 25/10 25/10
Cumulative survival
3 months (n ¼ alive, %) 26 (74%) 24 (69%)
6 months (n ¼ alive, %) 19 (54%) 21 (60%)
12 months (n ¼ alive, %) 13 (37%) 16 (46%)
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Results
We found significant differences between investigational
and control group for all outcome parameters (Table 2). The
patients in our investigational group with OWCwere signif-
icantly faster to achieve dry wound status. They also had
significantly shorter duration of antibiotic administration
and significantly shorter of hospital stay. The patients in the
conventional group on the other hand, who had undergone
wound closure with staples, required a mean of 3.3 more
days (95% CI: 2.09–4.45, p < 0.0001) to achieve dry wound
status, spent a mean of 2.5 more days (95% CI: 1.21–3.87, p
< 0.0003) on intravenous antibiotics, and remained a mean
of 1.8 more days (95% CI: 0.36–3.18, p < 0.0015) in hospi-
tal. As for prevention of PWD (Table 3), we found signifi-
cantly lower and more rapidly decreasing experimental
event rates in the investigational group at all time points,
as well as a steadily decreasing RR with time. After 1 week,
PWD was completely absent in the investigational group
(0%) but still present in 12 patients (34%) in the conven-
tional group. No more than three patients needed to be
treated (NNT  3) to avoid one occurrence of PWD over
4 or more days. Not surprisingly, we also found evidence of
very strong correlation between all outcome variables in the
conventional group (r ¼ 0.9 –1 [95% CI: 0.81–1], p <
0.0001).However, in the investigational group, the evidence
of correlation was only weak to moderate (r ¼ 0.34–0.58
[95% CI: 0.02–0.08], p < 0.0003–p < 0.048). Comparison
of Kaplan–Meier survival estimates of time to event
showed significant differences between investigational and
conventional group for time to dry wound (p < 0.0001),
time to cessation of antibiotics (p < 0.0001), and time to
hospital discharge (p ¼ 0.01) at all time points (Figures 1
to 3). Cox regression analysis, adjusted for gender, age,
and tumor growth rate, revealed identical unadjusted and
adjusted Cox model HR estimates of 3.7 for type of wound
closure (95% CI: 2.13–6.52, p < 0.0001 vs. 95% CI: 2.10–
6.60, p < 0.0001) and 2.3 for duration of antibiotic admin-
istration (95% CI: 1.37–3.93, p < 0.002 vs. 95% CI: 1.37–
3.93, p < 0.005). For time to hospital discharge, the unad-
justed Cox model HR estimate of 1.8 (95% CI: 1.07–2.90,
p < 0.02) was slightly attenuated to 1.7 (95% CI: 1.03–
2.80, p < 0.07) when adjusting for gender, age, and tumor
growth rate.
Discussion
Optimal soft tissue and wound management are essential
components of any orthopedic reconstructive procedure
and are critically important, particularly in joint replace-
ment surgery, if the increased rate of wound-related com-
plications associated with PWD is to be kept to a
minimum.14 There is clear evidence that closure of the
subcutaneous tissues significantly decreases the amount
Table 2. Effect of wound closure method on PWD.
PWD Treatment Total Cases Risks RR ¼ p1/p0 RD ¼ P1 – P0 NNT ¼ 1/absolute of RD
4 days Staples 35 32 0.91
0.44 –0.51 2
OWC 35 14 0.4
5 days Staples 35 25 0.71
0.2 –0.57 2
OWC 35 5 0.14
6 days Staples 35 17 0.49
0.12 –0.43 2
OWC 35 2 0.06
7 days Staples 35 12 0.34
0 –0.34 3
OWC 35 0 0
PWD: prolonged wound drainage; RR: risk ratio; RD: risk difference; NNT: number needed to treat; OWC: occlusive wound closure.
aRR ¼ p1/p0.
bRD ¼ P1 – P0.
cNNT ¼ 1/absolute of RD.
Table 3. Outcomes according to method of wound closure.
Outcome
Method of
wound closure N
Mean
(days) 95% CI
Range
(days)
Hazard ratios (95% CI)
Crude Adjusted*
Dry Wound Staples 35 6.71 5.58–7.85 3–18 Reference Reference
OWC 35 3.4 3.04–3.76 2–6 3.73 (2.13–6.52) 3.72 (2.10–6.60)
Antibiotic Treatment Staples 35 6.77 5.59– 7.96 3–19 Reference Reference
OWC 35 4.23 3.73–4.73 2–9 2.3 (1.37– 3.88) 2.32 (1.37– 3.93)
Hospital discharge Staples 35 8.03 6.86–9.20 4–20 Reference Reference
OWC 35 6.26 5.56– 7.86 3–12 1.76 (1.07–2.9) 1.7 (1.03–2.8)
OWC: occlusive wound closure.
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of wound discharge15 as well as the incidence of wound
complications16; however, the optimal skin closure method
for arthroplasty procedures in particular is more controver-
sial. Skin adhesives have some obvious advantages similar
to absorbable intra-cutaneous sutures, such as avoidance of
trauma associated with staples and a dedicated removal
procedure. However, several randomized prospective trials
have been unable to show clinically relevant differences in
wound complications, length of stay, patient satisfac-
tion,17–20 or cosmesis.19,20 A recent systematic review has
even found low-quality evidence suggesting that sutures
may be significantly better in minimizing wound dehis-
cence compared to skin adhesives.20 While almost all
authors recognize that most evidence originates from stud-
ies with substantial methodological limitations, a meta-
analysis comparing sutures versus staples for skin closure
in orthopedic surgery could nevertheless conclude that the
risk of wound infections was significantly higher with sta-
ples and recommends against their use, especially in
patients undergoing hip or knee surgery.21 There is also
emerging evidence that the combination of an absorbable
intra-cutaneous suture with a skin adhesive may be bene-
ficial in patient populations that are particularly prone to
postoperative wound complications and infection, such as
acetabular fracture surgery.22 This study is the first descrip-
tion of a skin closure method (OWC) combining three
established individual techniques in a synergistic fashion,
with a specific aim toward maximal stable wound edge
approximation and early wound occlusion in order to
reduce PWD. Our study is also the first report of the effi-
cacy of this new skin closure method in a well-documented,
high-risk patient population, where it achieved highly sig-
nificant and more importantly, clinically relevant reduc-
tions of the primary and secondary outcome measures
(PWD, length of antibiotic administration and length of
hospital stay) in comparison to conventional closure with
staples. The rates of PWD observed with conventional skin
staples in our study population (34%) compare well with a
previous study,11 which identified even higher PWD rates
associated with skin closure with staples (48%), as it also
included patients with bone sarcoma, total femur replace-
ment, or pelvic reconstruction for pathologic acetabular
fractures, which proved to be independent risk factors for
PWD. Both studies indicate that the use of conventional
skin closure with skin staples may predispose to significant
risk of PWD in tumor arthoplasty procedures involving the
hip. Although the primary objective of this study was to
determine the clinical effect of OWC on the primary out-
come measure PWD, our results also showed that OWC
indirectly affected both secondary outcome measures in a
different fashion. While a very strong correlation of PWD
with duration of administration of postoperative intrave-
nous antibiotics is not surprising, it is a direct function of
consequent application of our institutional policy not to
discontinue prophylactic intravenous antibiotics before the
surgical wound is completely dry; a lesser degree of corre-
lation between PWD and length of hospital stay was like-
wise to be expected, since this outcome variable obviously
depends on a multitude of other factors and not only the
wound condition alone. However, the modest attenuation
Figure 1. Kaplan–Meier survival function estimates for time to
dry wound status.
Figure 2. Kaplan–Meier survival function estimates for duration
of antibiotic administration.
Figure 3. Kaplan–Meier survival function estimates for time to
discharge from hospital.
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of the Cox model HR estimate, when adjusting for typical
confounders such as gender, age, and tumor growth rate,
also indicates that PWD still had a significant influence on
hospital stay in a relevant portion of our cohort and that
OWC therefore also might have a potential cost saving
effect. As formal investigation of the cost effectiveness
of OWC was not part of our study, it would be interesting
to conduct a formal cost-benefit analysis as part of a future
study. One challenge of studies like ours is to ensure per-
fectly balanced samples that are appropriately stratified or
matched for all conceivable variables (known or unknown)
that may affect the outcome of interest when the patient
population is rather inhomogeneous and the sample sizes
are relatively small. Based on experience and results from
a previous study on incidence and potential risk factors for
PWD in a similar patient population,11 we have chosen the
methodology (frequency matching) that best possibly
allowed risk stratification in advance, thereby ensuring
an equal distribution of the confounding factors we con-
sidered most relevant (age, gender, extent of resection,
hemiarthroplasty vs. total endoprosthesis, and presence
or absence of a pathological fracture). We acknowledge
that there may be other risk factors with a potential impact
on surgical wound healing, such as comorbidities, duration
of surgery, duration of surgical wound drainage, and so on,
which we did not explicitly match for, but we believe that a
substantial imbalance between our study groups in that
regard is not very likely. The effect of OWC even appears
to be strong enough to maintain its significant advantage
over conventional skin staples despite considerably
decreased usage of deep surgical wound drains in our
investigational cohort, which in actual fact could be
regarded as an at least potential additional risk factor for
PWD in itself. The strength of this skin closure method is
the synergy of its components. The absorbable intra-
cutaneous suture achieves primary wound edge approxi-
mation and contributes to the overall strength of the skin
closure, thereby minimizing the risk of secondary wound
dehiscence. The Steri-Strips™ optimize the skin approxi-
mation, relive tension at the wound edges, and aid in main-
taining the skin adhesive in situ while it is still in liquid
phase. Finally, the skin adhesive seals the incision, effec-
tively occluding the wound completely once set, that is,
even before application of the sterile dressing. The dis-
advantages of this method are that it is time-consuming
and more expensive than standard wound closure tech-
niques. The strengths of our study are the highly consis-
tent application of the relevant surgical technique by very
experienced surgeons, the excellent comparability of both
patient groups due to high conformity of relevant patient
demographics and matching criteria and its adequate
power due to high incidence of the primary outcome and
the effect size of the intervention studied. The limitations
of our study are the lack of formal randomization and
blinding.
Conclusion
We describe a novel skin closure method designed to mini-
mize postoperative wound complications. Compared to
conventional staples, this novel method, which we have
termed OWC, appears to significantly reduce postopera-
tive PWD, use of antibiotics, and hospital stay in patients
undergoing tumor arthroplasty procedures of the hip. It is
possible that the clinically relevant reduction of post-
operative wound complications achieved with this wound
closure method may also translate into a reduction of the
substantially increased risk for PJI in this particular
patient population. Longer follow-up and larger study
populations will be required to confirm this hypothesis.
In the meantime, this promising wound closure technique
warrants further investigation in similarly challenging
patient populations and more widespread use for other
indications where effective reduction of postoperative
wound complications is desired.
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